Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HLA-DOB Protein (AA 27-116) (GST tag)

HLA-DOB Origin: Human Host: Wheat germ Recombinant ELISA, WB, AP, AA
Catalog No. ABIN1306748
  • Target See all HLA-DOB Proteins
    HLA-DOB (Major Histocompatibility Complex, Class II, DO beta (HLA-DOB))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 27-116
    Origin
    • 3
    • 1
    Human
    Source
    • 1
    • 1
    • 1
    • 1
    Wheat germ
    Purification tag / Conjugate
    This HLA-DOB protein is labelled with GST tag.
    Application
    ELISA, Western Blotting (WB), Affinity Purification (AP), Antibody Array (AA)
    Purpose
    HLA-DOB (Human) Recombinant Protein (Q01)
    Sequence
    TDSPEDFVIQ AKADCYFTNG TEKVQFVVRF IFNLEEYVRF DSDVGMFVAL TKLGQPDAEQ WNSRLDLLER SRQAVDGVCR HNYRLGAPFT
    Characteristics
    Human HLA-DOB partial ORF ( NP_002111, 27 a.a. - 116 a.a.) recombinant protein with GST-tag at N-terminal.
    Purification
    in vitro wheat germ expression system
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Preparation method: in vitro, wheat germ expression system
    Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue.

    Restrictions
    For Research Use only
  • Buffer
    50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.
    Handling Advice
    Aliquot to avoid repeated freezing and thawing.
    Storage
    -80 °C
    Storage Comment
    Best use within three months from the date of receipt of this protein.
  • Target
    HLA-DOB (Major Histocompatibility Complex, Class II, DO beta (HLA-DOB))
    Alternative Name
    HLA-DOB (HLA-DOB Products)
    Synonyms
    DOB Protein, major histocompatibility complex, class II, DO beta Protein, HLA-DOB Protein, PATR-DOB Protein
    Background
    Full Gene Name: major histocompatibility complex, class II, DO beta
    Synonyms: DOB
    Gene ID
    3112
    NCBI Accession
    NM_002120
    Pathways
    Cancer Immune Checkpoints
You are here:
Support